ClinLabNavigator Logo
Analyzing Samples
Available Test Interpretations
C1 Esterase Inhibitor
C Reactive Protein
C Reactive Protein High Sensitivity
CA 125
CA 153
CA 19.9
CA 27.29
Caffeine
Calcitonin
Calcium
Calcium Ionized
Carbamazepine
Carbon Dioxide
Carbon Monoxide
Carcinoembryonic Antigen
Carcinoid Syndrome
Cardiac Marker Panel
Cardiovascular Risk Panel
Carotene
CCP Antibody
CD4 Enumeration
Celiac Disease Panel
Centromere Antibody
Cephalothin Antibody
Cerebrospinal Fluid
Ceruloplasmin
Chemistry Panels
Chlamydia Detection
Chloride
Cholesterol
Cholinesterase
Clindamycin Resistance
Clostridium Difficile
Coagulation Factor Assays
Coagulation Factor Inhibitor
Coagulation Screen
Cold Agglutinin Titer
Colloid Osmotic Pressure
Complement Profile
Complete Blood Count
Congenital Adrenal Hyperplasia
Cord Blood Gases
Cord Blood Studies
Corticotropin Releasing Hormone Stimulation Test
Cortisol
Cortisol in Critical Illness
Cortisol Salivary
Cortisol Urine Free
Cortrosyn Stimulation Test
Cotinine
Creatine Kinase
Creatine Kinase MB
Creatinine
Creatinine Clearance
Creatinine Kinase Isoenzymes
Crossmatch
CRP
Cryoglobulin
Cryptococcal Antigen
Cryptosporidium Antigen
Crystal Identification
Cushing Syndrome
Cyclosporine
Cystic Fibrosis
Cytogenetic Studies
Cytomegalovirus Antibody
Cytomegalovirus Culture
Cytomegalovirus PCR Qualitative
Cytomegalovirus PCR Quantitative
Test Interpretations
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C1 Esterase Inhibitor

Print This Page
E-mail This Page

C1 esterase inhibitor is a serum alpha-2 globulin and a member of the serpin family of protease inhibitors that is synthesized by the liver. Its physiologic function is inhibition of the catalytic subunits of the first component of the classic complement pathway (C1r and C1s). Deficiency of C1 esterase inhibitor results in the inappropriate activation of C1 and generation of C2 kinin. The latter molecule increases vascular permeability and is believed to be the mediator of the angioedema observed in patients with C1 esterase inhibitor deficiency. Edema involves the subcutaneous tissue, gastrointestinal tract and respiratory tract.



There are two forms of C1 esterase inhibitor deficiency. The inherited form is usually detected in the first or second decade of life and has an autosomal dominant pattern of inheritance. The acquired form primarily affects adult or elderly patients with autoimmune or lymphoproliferative disorders.

In the inherited form of C1 esterase inhibitor deficiency, there is either a quantitative or qualitative defect in the synthesis of the C1 esterase inhibitor protein. The more common form of hereditary angioneurotic edema (85% of cases) is due to an absolute decrease in the synthesis of the C1esterase inhibitor. The less common form (15% of cases) is due to production of normal quantities of a functionally deficient protein. In both hereditary subtypes, C1 activation proceeds unabated, resulting in normal levels of C1q. Levels of C2 and C4 are decreased because of the uncontrolled activity of C1s.

Patients with the acquired form of C1 esterase inhibitor deficiency produce immune complexes that consume large amounts of C1q and C1 esterase inhibitor, resulting in quantitative and functional deficiency of the C1 esterase inhibitor and C1q. C2 and C4 levels are also decreased.



Differentiation of Acquire and Hereditary Deficiencies

Type of Deficiency

C1q Levels

C2 & C4 Levels

Inherited

Normal

Decreased

Acquired

Decreased

Decreased



Reference range is 18 - 40 mg/dL.

Specimen requirement is one lavender (EDTA) tube of blood.